• About us
• Contact

Advertisement

Organisation › Details

FerGene (Ferring / Blackstone Life Sciences)

FerGene, a new gene therapy company and Ferring subsidiary, has been created to potentially commercialize nadofaragene firadenovec in the U.S. and to advance the global clinical development. FerGene’s goal is to bring this promising therapy to a patient population which has seen little improvement in their standard of care over the past twenty years. Blackstone Life Sciences will invest $400 million USD and Ferring will invest up to $170 million USD in FerGene. Ferring will also potentially launch and commercialize nadofaragene firadenovec outside of the U.S. *

 

	Start	2019-11-25 established jv
	Group	Ferring (Paulsen Foundation) (Group)
	Industry	nadofaragene firadenovec (rAd-IFN/Syn3)
	Industry 2	drug development
	Region	United States (USA)_oo
	Country	United States (USA)
	City	n. a.
		Address record changed: 2019-11-27
Basic data	Employees	n. a.
		* Document for »About Section«: Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC.
		Record changed: 2023-07-10

Advertisement

More documents for Ferring (Paulsen Foundation) (Group)

• [1] Ipsen S.A.. (12/18/19). "Press Release: Ipsen Announces Departure of David Meek as Chief Executive Officer". Paris....
• [2] Ferring Pharmaceuticals S.A.. (12/18/19). "Press Release: FerGene Appoints David Meek Chief Executive Officer". Cambridge, MA....
• [3] Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC....
• [4] Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA....
• [5] Ferring Pharmaceuticals S.A.. (4/5/18). "Press Release: Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.". Saint-Prex & Roseville, MN....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.